Cellulite Treatment in El Monte CA
Cellulite Treatment
Cellulite is a skin condition commonly situated in the hips, thighs and buttocks. It has a cottage cheese appearance and multiple dimples on the skin. It is not related to being overweight but is genetic.
Cellulite treatment is not a surgical procedure. Treatment does not break the skin. It is a safe non-surgical approach to body contouring.
Best candidates are men and women who are in good health, have good skin tone and have realistic expectations. The results will produce an improvement in skin tone, the appearance of stretchmarks, and loose skin may be improved.
It is recommended to add diet and exercise to daily routine while undergoing cellulite treatments.
The cellulite treatment called Mesotherapy is considered very effective. The cellulite area develops increased blood flow and lymphatic flow, decreased fibrosis of the connective tissue and reduction of fat deposits. The result is smooth skin and cellulite reduction. This type of cellulite treatment uses a mixture of substances including vitamins, herbs and other homeopathic medications. This treatment is custom-tailored for each individual. Very short and thin needles re used to inject the formulations.
When treating cellulite, one formulation of medications may be used to dissolve fat, and another to destroy fibrous bands that bind the skin. This treatment is virtually painless. One can return to normal activities immediately.
The risks involved in this treatment are the possibility of allergic reaction to the mesotherapy solution. Since a needle is used, there is a possibility of infection at the site of injections. Mild or minor bruising at injection site is also a possibility. There may also be some itching after the treatment.
This procedure is performed in a medical setting. The patient does not need anesthesia. No post-operative recovery time. For those with sensitive skin, an anesthetic cream can be applied 1/2 hour before the treatment.
Another cellulite treatment is Lipodissolve. This is also a non-surgical procedure. This cellulite treatment involves the injection of phosphatidylcholine (PPC) into small fat deposits to dissolve fat. PPC is a natural enzyme. This compound is injected into the fat through multiple microinjections. The treatment is to dissolve fat which is removed through normal waste removal. It is virtually painless. No heavy bandages and one can resume work with no down time.
The procedure takes 30-60 minutes depending on areas treated. The patient can return to normal activities after the procedure.
The risks involved are the same as the above treatment. Plus the patient might feel light-headedness or slight nausea. This should pass quickly. The area treated will be swollen and tender for a few days and up to a few weeks.
SmartLipo, also known as laser liposuction is the latest fat removal treatment. This procedure involves the use of a laser that dissolves the fat and tightens the surrounding skin. This treatment is done in an office and does not require general anesthetic. The doctor will mark the targeted areas and local anesthetic is given. A small tube containing a laser is inserted into the skin. The laser's energy causes the fat cells to rupture and drain away. This is removed by the body's waste system. With this cellulite treatment, there is less bleeding and swelling. This causes the skin to tighten and shrink gradually in about 6-8 weeks.
The risks involved in this procedure are mild swelling, bruising or tenderness at site of insertion. There is rarely infection and a possibility of haematoma (collection of blood underneath the skin) following treatment. Asymmetrical results and minor scarring can be long term risks.
Best results are seen after 2 months. Downtime is minimal. The patient can return to work within 24 hours.
More El Monte info...
El Monte Sleep
Motel 6 Los Angeles - El Monte, 3429 Peck Road, ? +1 626 448-6660 (fax: +1 626 279-5664), [3].
El Monte By Plane
For commercial passengers, the closest major airports are Burbank (IATA: BUR) 30 miles northwest, and Ontario (IATA: ONT), 30 miles east.
El Monte Airport (ICAO: KEMT) is a popular destination for general aviation private pilots. While it is a controlled field, it has fairly low traffic for an LA metro field.
Plastic Surgery News...
- UroToday.com - Posters #21 and #22: These presentations focused on the development and implementation of a curriculum for urodynamic teaching for urology residents.
- The European Medicines Agency’s (EMEA) has issued a public statement on the risk of peripheral neuropathy with Sebivo® (telbivudine). The statement is given below (direct from source):
The European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has recommended that new warnings be included in the product information for Sebivo (telbivudine), from Novartis Europharm Ltd. This warning is intended to inform doctors about the risk of peripheral neuropathy in patients with chronic hepatitis B who are being treated with Sebivo.
Doctors are advised to monitor patients carefully for signs of peripheral neuropathy and to reconsider treatment options if they suspect that a patient is developing peripheral neuropathy. Sebivo is indicated for the treatment of chronic hepatitis B in adult patients with compensated liver disease and evidence of viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active inflammation and/or fibrosis as monotherapy only.
Cases of peripheral neuropathy have been uncommonly reported in patients treated with telbivudine as monotherapy. In a clinical trial investigating the combination therapy of telbivudine 600 mg daily with pegylated interferon alfa-2a 180 mcg once weekly, an increased risk of peripheral neuropathy was observed.
The CHMP, after evaluating the available data, has recommended the inclusion of the following warning in the product information for Sebivo:
Peripheral neuropathy has been uncommonly reported in telbivudine-treated patients. If peripheral neuropathy is suspected, treatment with telbivudine should be reconsidered (see section 4.8).
An increased risk of peripheral neuropathy has been observed when telbivudine and pegylated interferon alfa-2a are co-administered (see section 4.5). Such increased risk cannot be excluded for other interferons alfa (pegylated or standard). Moreover, the benefit of this combination of telbivudine with interferon alfa (pegylated or standard) is not currently established.
The statement can be accessed at the above link.